A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/08 (2006.01) A61P 5/50 (2006.01)
Patent
CA 2704651
The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 re-ceptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as insulin resistance.
La présente invention porte sur des ligands peptidiques des récepteurs de la mélanocortine, en particulier le récepteur de la mélanocortine-4, et, en tant que tels, sont utiles dans le traitement de troubles sensibles à l'activation de ce récepteur, tels que la résistance à l'insuline.
Butler Andrew A.
Culler Michael Dewitt
Halem Heather A.
Board Of Supervisors Of Louisiana State University And Agricultu
Ipsen Pharma S.a.s.
Smart & Biggar
LandOfFree
Use of melanocortins to treat insulin sensitivity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of melanocortins to treat insulin sensitivity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of melanocortins to treat insulin sensitivity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1672165